Coley presents Phase I/II data

Coley (Wellesley, Mass.) said that the combination of its CpG 7909 DNA-based immune stimulant and Engerix-B, a hepatitis B virus (HBV) vaccine marketed by SmithKline Beecham (LSE:SB; SBH), gave signif...